secwatch.observer — SEC 8-K summary
======================================

Issuer:     CDT Equity Inc. (CDT)
CIK:        0001896212
Form:       8-K
Filed at:   2025-03-06T23:59:59+00:00
Accession:  0001493152-25-009330
Event type: regulatory
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Conduit Pharmaceuticals receives Nasdaq extension, plans transfer to Capital Market
--------------------------------------------------------------------------------

- Nasdaq Hearing Panel granted extension to March 31, 2025 to regain MVPHS and MVLS compliance.
- Company must file application to transfer to Nasdaq Capital Market by March 12, 2025.
- Bid Price compliance regained as of February 26, 2025; extension conditional on meeting all listing rules.
- Company believes it can satisfy equity standard of >$2.5M stockholder's equity before deadline.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1896212/000149315225009330/0001493152-25-009330-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1896212/000149315225009330/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-009330

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer